Psoriasis care and cardiovascular events

Patients starting treatment for psoriasis vulgaris were monitored for changes in their cardiovascular risk factors

This longitudinal study followed the change in cardiovascular risk factors in patients starting treatment for psoriasis vulgaris over 12 weeks.

The study included 34 psoriasis patients (10 of whom received topical treatment, 11, narrow-band UVB radiation, and 13, PUVA) and 37 healthy controls. At baseline, patients with psoriasis had higher CRP, oxidised LDL and LDL than control subjects and no significant difference in lipid profile was observed following treatment.

Treatment with topical therapy resulted in reduced thiobarbituric acid reactivity, narrow-band UVB therapy resulted in consistently higher oxidised LDL/LDL, cholesterol/HDL, lipoprotein (a) and CRP than in controls and PUVA resulted in significant reduction in lipoprotein (a) and increase in apolipoprotein-B.

Patients with psoriasis undergo several lipid profile changes and those undergoing narrow-band UVB and PUVA have several cardiovascular risk factors.
Coimbra S. Am J Clin Dermatol 2010; 6: 423-32

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...